What is the safest way to stop postmenopausal hormone therapy?

What is the safest way to stop postmenopausal hormone therapy?
©2014 Mary Ann Liebert, Inc., publishers

When the time comes for postmenopausal women to discontinue hormone therapy (HT), little is known about the best way to do so with minimal symptoms. A new study that explores optimal approaches to manage symptoms such as trouble sleeping, mood swings, and depression on discontinuation of HT is published in Journal of Women's Health.

Many women will try and fail to stop using and patches intended to control menopausal symptoms, according to Katherine Newton, PhD and coauthors, Group Health Research Institute, University of Washington, UW School of Medicine, and Fred Hutchinson Cancer Research Institute, Seattle, and Harvard Medical School and Harvard Vanguard Medical Associates, Boston, MA.

They identify several characteristics of cessation that can increase the likelihood of its success in the article "Factors Associated with Successful Discontinuation of Hormone Therapy." Among these are the positive effects of a physician's advice and the importance of symptom management.

"It is important that we better understand experiences, practices, and attitudes related to discontinuation of hormone therapy in the post-Women's Health Initiative (WHI) era," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.

Journal information: Journal of Women's Health
Citation: What is the safest way to stop postmenopausal hormone therapy? (2014, February 11) retrieved 19 April 2024 from https://medicalxpress.com/news/2014-02-safest-postmenopausal-hormone-therapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study compares two commonly used estrogen drugs and cardiovascular safety

 shares

Feedback to editors